Potential low-density lipoprotein cholesterol, cardiovascular risk and costs reduction with evolocumab: a simulation in patients with a recent myocardial infarction in Spain
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Drug therapy
Session:
Risk Factors and Prevention ePosters